Brainstorm Cell Therapeutics reported $12K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Adamis Pharmaceuticals ADMP:US USD 15.05K 0
Biogen BIIB:US USD 100K 0
Brainstorm Cell Therapeutics BCLI:US USD 12K 0
Cytokinetics CYTK:US USD 93K 8K
Gilead Sciences GILD:US USD 1000K 0
Halozyme Therapeutics HALO:US USD 135K 3K
Idera Pharmaceuticals IDRA:US USD 59K 6K